Publication
Article
BioPharm International
Author(s):
by Kevin Robinson For "me too" manufacturers, the growth opportunity is in Europe ? and in biogenerics.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.